Last update 01 Nov 2024
Wuhan Hengxinyuan Pharmaceutical Co., Ltd.
Last update 01 Nov 2024
Overview
Tags
Nervous System Diseases
Hemic and Lymphatic Diseases
Neoplasms
Small molecule drug
Herbal medicine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
丹曲林钠胶囊在中国健康受试者中随机、开放、两制剂、单次给药、两周期交叉、餐后状态下生物等效性试验
[Translation] A randomized, open-label, two-dose, single-dose, two-period crossover, fed-state bioequivalence study of dantrolene sodium capsules in Chinese healthy subjects
丹曲林钠胶囊在中国健康受试者中随机、开放、两制剂、单次给药、四周期交叉、空腹状态下生物等效性试验。
[Translation] A randomized, open-label, two-dose, single-dose, four-period crossover bioequivalence study of dantrolene sodium capsules in Chinese healthy subjects under the fasting state.
评估509胶囊治疗局部晚期或转移性实体瘤的安全性、耐受性、药代动力学特征、有效性的Ⅰ期研究
[Translation] A phase I study to evaluate the safety, tolerability, pharmacokinetic characteristics, and efficacy of 509 capsules in the treatment of locally advanced or metastatic solid tumors
100 Clinical Results associated with Wuhan Hengxinyuan Pharmaceutical Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Wuhan Hengxinyuan Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Wuhan Hengxinyuan Pharmaceutical Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 06 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
1
Phase 2 Clinical
Approved
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free